Key result
Glucose-insulin-potassium (GIK) infusions provide beneficial effects in acute myocardial infarction, cardiogenic shock, and cardiac surgery, and may also benefit chronic heart failure.
Answers are grounded in this paper and cite their sources.
Glucose-insulin-potassium (GIK) infusions may offer cardiovascular benefits across acute myocardial infarction, cardiogenic shock, cardiac surgery, and chronic heart failure.
There is increasing evidence to support the beneficial eVects of glucose-insulin-potassium infusions (GIK) in acute myocardial infarction, cardiogenic shock, and cardiac surgery. An article in this issue suggests some benefits may also accrue during the treatment of chronic heart failure.
No takes yet. Share an insight, caveat, or question.
Broomhead et al. (2001) studied this question. Glucose-insulin-potassium (GIK) infusions provide beneficial effects in acute myocardial infarction, cardiogenic shock, and cardiac surgery, and may also benefit chronic heart failure.
Synapse has enriched 10 related papers. Consider them for comparative context: